OraSure Technologies Inc (OSUR)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $248.57M
Last updated: Nov 17, 2026 at 4:10 PM ET
OraSure Technologies Inc (OSUR) Statistics
OraSure Technologies (OSUR) has a market cap of $248.57M and an enterprise value of $100.33M. It holds $148.24M more cash than debt, 59.64% of its market cap. It kept -41.73% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 59.64% below the market cap, as cash exceeds debt.
| Market Cap | $248.57M |
|---|---|
| Enterprise Value | $100.33M |
| Latest price (Nov 17, 2026) | $3.51 |
Key Dates
The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.1x and 0.8x. Its year-end P/S ranged from 0.9x to 6.7x from 2016 to 2025.
| P/S Ratio | 2.1x |
|---|---|
| Forward P/S | 2.1x |
| P/B Ratio | 0.8x |
| P/TBV Ratio | 1.0x |
Price Statistics
The stock is up 51.95% over 52 weeks and trades 5.90% below its 50-day average.
| Beta (1Y) | 1.21 |
|---|---|
| 52-Week Change | +51.95% |
| 1-Month Change | -4.62% |
| 3-Month Change | -5.14% |
| 6-Month Change | +13.96% |
| 5-Year Change | -63.07% |
| 10-Year Change | -47.54% |
| Total Return (1Y) | +51.95% |
| Total Return (3Y CAGR) | -21.07% |
| Total Return (5Y CAGR) | -18.46% |
| Return vs SPY (1Y) | +54.01% |
| Max Drawdown (1Y) | -28.22% |
| Max Drawdown (3Y) | -74.73% |
| Sharpe Ratio (1Y) | 1.01 |
| Correlation with SPY (1Y) | 0.33 |
| 50-Day Average | $3.73 |
| 200-Day Average | $3.56 |
| 52-Week Range | $2.08 to $4.58 |
| RSI (14 Days) | 44.5 |
| Average Volume (20 Days) | 696.22K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 8.58x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 8.58x |
|---|---|
| Quick Ratio | 7.36x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -15.79% over the last 12 months, against a 5-year average of -4.64%.
| Return on Equity (ROE) | -15.79% |
|---|---|
| Return on Assets (ROA) | -13.88% |
| Return on Capital Employed (ROCE) | -13.91% |
| ROE (5Y Average) | -4.64% |
| ROA (5Y Average) | -3.77% |
| ROIC (5Y Average) | -17.98% |
| Asset Turnover | 0.30x |
| Inventory Turnover | 2.19x |
| Receivables Turnover | 4.15x |
| Cash Conversion Cycle | 210 days |
Scores
OSUR has an Altman Z-Score of 3.19, in the safe zone above 2.99, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.19 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $116.23M over the last 12 months is down 7.53% from the 12 months before.
| Revenue | $116.23M |
|---|---|
| Revenue Growth (YoY) | -7.53% |
| Gross Profit | $50.06M |
| Operating Income | -$50.89M |
| Pretax Income | -$45.12M |
| Net Income | -$48.51M |
| EBITDA | -$36.07M |
| EBIT | -$45.12M |
| Reported EPS (TTM) | -$0.84 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 87.88% of the $349.47M in total assets.
| Cash and Equivalents | $148.24M |
|---|---|
| Total Debt | $0 |
| Net Cash | $148.24M |
| Net Cash Per Share | $2.15 |
| Working Capital | $190.19M |
| Shareholder Equity | $307.13M |
| Book Value Per Share | $4.45 |
| Tangible Book Value | $245.63M |
| Tangible Book Per Share | $3.56 |
| Total Assets | $349.47M |
| Total Liabilities | $42.33M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $5.94M of capital spending, operating cash flow left -$49.62M of free cash flow.
| Operating Cash Flow | -$43.68M |
|---|---|
| Capital Expenditures | $5.94M |
| Free Cash Flow | -$49.62M |
| FCF Per Share | -$0.72 |
| Depreciation and Amortization | $10.32M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -43.78%, against a 5-year average of -15.96%.
| Gross Margin | 43.07% |
|---|---|
| Operating Margin | -43.78% |
| Pretax Margin | -38.82% |
| Net Margin | -41.73% |
| EBITDA Margin | -31.03% |
| EBIT Margin | -38.82% |
| FCF Margin | -42.69% |
| Gross Margin (5Y Average) | 43.12% |
| Operating Margin (5Y Average) | -15.96% |
| Net Margin (5Y Average) | -14.26% |
Growth
Revenue fell 33.29% a year over 3 years.
| Revenue Growth (3Y CAGR) | -33.29% |
|---|---|
| Revenue Growth (5Y CAGR) | -7.70% |
| Book Value Per Share Growth (2Y CAGR) | -8.92% |
| Tangible Book Per Share Growth (2Y CAGR) | -13.91% |
Dividends and Yields
OSUR does not pay a dividend. Its free cash flow yield is -20.49%.
| FCF Yield | -20.49% |
|---|---|
| Buyback Yield | 4.97% |
| Shareholder Yield | 4.97% |
Peer Position
Against 12 similar companies, OSUR has the 9th highest P/S.
P/S RatioPeer median 2.7x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.01%
| P/S Ratio | 2.1x vs 2.7x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -7.53% vs +9.01% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.82% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.82% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OSUR
What is OSUR's market cap?
OraSure Technologies has a market cap of $248.57M. Its enterprise value, which adds debt and subtracts cash, is $100.33M.
How many shares of OSUR are outstanding?
OraSure Technologies has 69.00M shares outstanding. The count is down 5.48% from a year earlier.
Does OSUR pay a dividend?
No. OraSure Technologies does not pay a dividend.
How much debt does OSUR have?
OraSure Technologies has $0 of total debt and $148.24M of cash and equivalents, a net cash position of $148.24M.
OSUR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts